Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Oliver G Ottmann

Showing results (31-40 of 102) with videos related to

Pageof 11
Sort By:
International Journal of Hematology|February 26, 2004
Antiproliferative efficacy of the third-generation bisphosphonate, zoledronic acid, combined with other anticancer drugs in leukemic cell linesShinya Kimura, Junya Kuroda, Hidekazu Segawa, et al.
Haematologica|May 10, 2007
Effect of histone deacetylase inhibitor valproic acid on progenitor cells of acute myeloid leukemiaGesine Bug, Kerstin Schwarz, Claudia Schoch, et al.
Leukemia Research|December 15, 2015
Blockade of thymic stromal lymphopoietin (TSLP) receptor inhibits TSLP-driven proliferation and signalling in lymphoblasts from a subset of B-precursor ALL patientsTina Vetter, Andreas Borowski, Andreas Wohlmann, et al.
Leukemia & Lymphoma|November 6, 2020
Smoothened inhibitor erismodegib combined with nilotinib in patients with chronic myeloid leukemia resistant/intolerant to at least one prior tyrosine kinase inhibitor: a phase 1b studyOliver G Ottmann, Frank Stegelmann, Massimo Breccia, et al.
International Journal of Oncology|April 30, 2013
Characterization of ZC3H15 as a potential TRAF-2-interacting protein implicated in the NFκB pathway and overexpressed in AMLGianni Capalbo, Thea Mueller-Kuller, Steffen Koschmieder, et al.
Journal of Cellular and Molecular Medicine|March 24, 2016
CD19-CAR engineered NK-92 cells are sufficient to overcome NK cell resistance in B-cell malignanciesAnnette Romanski, Christoph Uherek, Gesine Bug, et al.
Oncology Reports|September 7, 2013
Endoplasmic reticulum protein GliPR1 regulates G protein signaling and the cell cycle and is overexpressed in AMLGianni Capalbo, Thea Mueller-Kuller, Steffen Koschmieder, et al.
Lancet (London, England)|February 21, 2002
Relation between resistance of Philadelphia-chromosome-positive acute lymphoblastic leukaemia to the tyrosine kinase inhibitor STI571 and gene-expression profiles: a gene-expression studyWolf K Hofmann, Sven de Vos, David Elashoff, et al.
Stem Cells (Dayton, Ohio)|June 16, 2005
Transcriptional profiling of human hematopoiesis during in vitro lineage-specific differentiationMartina Komor, Saskia Güller, Claudia D Baldus, et al.
Cancer Genetics and Cytogenetics|July 29, 2008
Establishment and cytogenetic characterization of a human acute lymphoblastic leukemia cell line (ALL-VG) with ETV6/ABL1 rearrangementJoerg Baeumler, Karoly Szuhai, J H Frederik Falkenburg, et al.
Pageof 11

Showing results (31-40 of 102) with videos related to

Sort By:
Pageof 11
International Journal of Hematology|February 26, 2004
Antiproliferative efficacy of the third-generation bisphosphonate, zoledronic acid, combined with other anticancer drugs in leukemic cell linesShinya Kimura, Junya Kuroda, Hidekazu Segawa, et al.
Haematologica|May 10, 2007
Effect of histone deacetylase inhibitor valproic acid on progenitor cells of acute myeloid leukemiaGesine Bug, Kerstin Schwarz, Claudia Schoch, et al.
Leukemia Research|December 15, 2015
Blockade of thymic stromal lymphopoietin (TSLP) receptor inhibits TSLP-driven proliferation and signalling in lymphoblasts from a subset of B-precursor ALL patientsTina Vetter, Andreas Borowski, Andreas Wohlmann, et al.
Leukemia & Lymphoma|November 6, 2020
Smoothened inhibitor erismodegib combined with nilotinib in patients with chronic myeloid leukemia resistant/intolerant to at least one prior tyrosine kinase inhibitor: a phase 1b studyOliver G Ottmann, Frank Stegelmann, Massimo Breccia, et al.
International Journal of Oncology|April 30, 2013
Characterization of ZC3H15 as a potential TRAF-2-interacting protein implicated in the NFκB pathway and overexpressed in AMLGianni Capalbo, Thea Mueller-Kuller, Steffen Koschmieder, et al.
Journal of Cellular and Molecular Medicine|March 24, 2016
CD19-CAR engineered NK-92 cells are sufficient to overcome NK cell resistance in B-cell malignanciesAnnette Romanski, Christoph Uherek, Gesine Bug, et al.
Oncology Reports|September 7, 2013
Endoplasmic reticulum protein GliPR1 regulates G protein signaling and the cell cycle and is overexpressed in AMLGianni Capalbo, Thea Mueller-Kuller, Steffen Koschmieder, et al.
Lancet (London, England)|February 21, 2002
Relation between resistance of Philadelphia-chromosome-positive acute lymphoblastic leukaemia to the tyrosine kinase inhibitor STI571 and gene-expression profiles: a gene-expression studyWolf K Hofmann, Sven de Vos, David Elashoff, et al.
Stem Cells (Dayton, Ohio)|June 16, 2005
Transcriptional profiling of human hematopoiesis during in vitro lineage-specific differentiationMartina Komor, Saskia Güller, Claudia D Baldus, et al.
Cancer Genetics and Cytogenetics|July 29, 2008
Establishment and cytogenetic characterization of a human acute lymphoblastic leukemia cell line (ALL-VG) with ETV6/ABL1 rearrangementJoerg Baeumler, Karoly Szuhai, J H Frederik Falkenburg, et al.
Pageof 11